MEDICURE ANNOUNCES FINANCIAL RESULTS FOR FISCAL FIRST QUARTER 2006

Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company, today reported the results of operations for the three-month period ended August 31, 2005. All amounts referenced herein are in Canadian dollars unless otherwise noted. The quarter was highlighted by the Company raising gross proceeds of $4,685,000 through a private placement. At August 31, 2005 the Company had cash and cash equivalents totaling $7,573,000 as compared to $7,591,000 as at May 31, 2005. The cash position is sufficient to advance the Company's lead products, MC-1 and MC-4232, up to pivotal Phase III studies.

CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&actionFor=562442)